Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Building an RNA Sequencing Transcriptome of the Central Nervous System.
Multiple sclerosis care in Latin America.
An anomalous case of acute coronary syndrome: the unexpected autoimmune duo.
Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis.
Neuromyelitis Optica Preceded by HyperCKemia and a Possible Association with Coxsackie Virus Group A10 Infection.
Evidence linking HHV-6 with multiple sclerosis: an update.
A novel data mining system points out hidden relationships between immunological markers in multiple sclerosis.
A discrete-choice experiment to determine patient preferences for injectable multiple sclerosis treatments in Germany.
Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis.
Pathogenesis of multiple sclerosis: what can we learn from the cuprizone model.
Whole-Brain In-vivo Measurements of the Axonal G-Ratio in a Group of 37 Healthy Volunteers.
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
The role of iron in brain ageing and neurodegenerative disorders.
A Group Kickboxing Program for Improving Balance, Mobility, and Quality of Life in Individuals With Multiple Sclerosis: A Pilot Study.
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis.
Grey matter lesions in MS: From histology to clinical implications.
Multiple sclerosis: Atacicept increases relapse rates in multiple sclerosis.
Placebo-controlled study in neuromyelitis optica-Ethical and design considerations.
Multiple sclerosis: A distinct disease course for paediatric multiple sclerosis.
Multiple sclerosis: Interaction between IFN-β and vitamin D in modulation of MS risk.
Fatigue in Multiple Sclerosis: Neural Correlates and the Role of Non-Invasive Brain Stimulation.
Chronic cerebrospinal venous insufficiency is not associated with cognitive impairment in multiple sclerosis.
Acute combined central and peripheral demyelination showing anti-aquaporin 4 antibody positivity.
Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies.
Pages
« first
‹ previous
…
236
237
238
239
240
241
242
243
244
…
next ›
last »